Barbara Dudley Alexander
#66,170
Most Influential Person Now
American infectious disease physician
Barbara Dudley Alexander's AcademicInfluence.com Rankings
Barbara Dudley Alexandermedical Degrees
Medical
#885
World Rank
#1145
Historical Rank
#302
USA Rank
Public Health
#605
World Rank
#625
Historical Rank
#93
USA Rank
Barbara Dudley Alexanderphilosophy Degrees
Philosophy
#9867
World Rank
#13486
Historical Rank
#1787
USA Rank
Logic
#7879
World Rank
#9801
Historical Rank
#1241
USA Rank
Download Badge
Medical Philosophy
Barbara Dudley Alexander's Degrees
- Bachelors Biology Stanford University
- Doctorate Medicine Harvard University
- Masters Public Health Johns Hopkins University
Similar Degrees You Can Earn
Why Is Barbara Dudley Alexander Influential?
(Suggest an Edit or Addition)According to Wikipedia, Barbara Dudley Alexander is an American infectious disease physician. She is a professor of medicine and pathology at the Duke University School of Medicine. Alexander earned an M.D. at ECU Brody School of Medicine in 1993. She completed a residency in medicine at Duke University. She conducted fellowships in infectious diseases and medical microbiology at Duke University. Alexander was president of the Infectious Diseases Society of America.
Barbara Dudley Alexander's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. (2010) (1246)
- Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). (2010) (1214)
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (2019) (1062)
- Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients (2004) (789)
- Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. (2005) (632)
- Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. (2013) (627)
- Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. (2005) (354)
- Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting (2007) (334)
- Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. (2003) (334)
- Factors associated with mortality in transplant patients with invasive aspergillosis. (2010) (277)
- Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network (2009) (259)
- Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006 (2011) (252)
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints (2008) (250)
- An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. (2005) (225)
- Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. (2007) (221)
- Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. (2003) (219)
- Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance (2016) (203)
- Breakthrough Invasive Candidiasis in Patients on Micafungin (2010) (192)
- CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. (2013) (178)
- Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. (2004) (160)
- Contemporary Tools for the Diagnosis and Management of Invasive Mycoses (2006) (157)
- Multicenter Evaluation of the Candida albicans/Candida glabrata Peptide Nucleic Acid Fluorescent In Situ Hybridization Method for Simultaneous Dual-Color Identification of C. albicans and C. glabrata Directly from Blood Culture Bottles (2007) (148)
- Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. (2008) (144)
- Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients (2005) (144)
- Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. (2008) (136)
- Wild-Type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods (2009) (132)
- Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. (2012) (131)
- Infectious complications of lung transplantation (2001) (129)
- The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET) (2016) (127)
- The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary. (2016) (125)
- Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. (2011) (125)
- Multicenter Evaluation of a Candida albicans Peptide Nucleic Acid Fluorescent In Situ Hybridization Probe for Characterization of Yeast Isolates from Blood Cultures (2005) (122)
- Quantitation of Candida CFU in Initial Positive Blood Cultures (2011) (121)
- Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. (2006) (120)
- Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal Agents (2007) (119)
- Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network (TRANSNET) (2014) (117)
- Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients (2005) (114)
- Clinical Utility of Cytomegalovirus Viral Load Testing for Predicting CMV Disease in D+/R‐ Solid Organ Transplant Recipients (2004) (108)
- Prospective Aspergillus Galactomannan Antigen Testing in Pediatric Hematopoietic Stem Cell Transplant Recipients (2007) (107)
- β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study (2012) (105)
- Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay (2011) (99)
- Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation (2017) (96)
- The (1,3)β-d-Glucan Test as an Aid to Early Diagnosis of Invasive Fungal Infections following Lung Transplantation (2010) (95)
- Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. (2005) (93)
- Diagnosis of fungal infection: new technologies for the mycology laboratory. (2002) (93)
- Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. (1997) (92)
- Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis. (2017) (92)
- Calcineurin Inhibitor Agents Interact Synergistically with Antifungal Agents In Vitro against Cryptococcus neoformans Isolates: Correlation with Outcome in Solid Organ Transplant Recipients with Cryptococcosis (2007) (92)
- Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. (2000) (87)
- Quantification of 1,3-β-d-Glucan Levels in Children: Preliminary Data for Diagnostic Use of the β-Glucan Assay in a Pediatric Setting (2007) (86)
- Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia. (2011) (85)
- Posaconazole as Salvage Therapy in Patients With Invasive Fungal Infections After Solid Organ Transplant (2008) (83)
- Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study. (2012) (81)
- Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole. (2005) (79)
- Epidemiology of Invasive Mold Infections in Lung Transplant Recipients (2014) (78)
- Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression. (2015) (77)
- Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). (2015) (74)
- Risk Factors for Cytomegalovirus Viremia and Disease Developing after Prophylaxis in High-Risk Solid-Organ Transplant Recipients (2004) (73)
- Antifungal Management Practices and Evolution of Infection in Organ Transplant Recipients with Cryptococcus Neoformans Infection (2005) (71)
- Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. (2010) (71)
- Fungal infections in transplant and oncology patients. (2011) (67)
- Antifungal Activities of SCY-078 (MK-3118) and Standard Antifungal Agents against Clinical Non-Aspergillus Mold Isolates (2015) (67)
- Viral infections after renal transplantation. (2001) (67)
- Sepsis, Multiple Organ Failure, and Death Due to Pandoraea pnomenusa Infection after Lung Transplantation (2003) (66)
- Risk Factors for Burkholderia cepacia Complex Bacteremia Among Intensive Care Unit Patients Without Cystic Fibrosis: A Case-Control Study (2007) (65)
- Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures (2007) (64)
- CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival (2016) (62)
- Central Nervous System Cryptococcosis in Solid Organ Transplant Recipients: Clinical Relevance of Abnormal Neuroimaging Findings (2008) (62)
- Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood (2012) (61)
- Invasive Fungal Infection after Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis. (2019) (60)
- Cost of Invasive Fungal Infections in the Era of New Diagnostics and Expanded Treatment Options (2012) (58)
- Severity of Clostridium difficile‐associated diarrhea in solid organ transplant patients (2007) (58)
- Study of renal safety in amphotericin B lipid complex-treated patients. (2005) (58)
- Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. (2009) (57)
- Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis (2018) (55)
- Aspergillus DNA contamination in blood collection tubes. (2010) (54)
- Non‐comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation (2006) (54)
- Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens. (2010) (53)
- Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing (2016) (53)
- Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. (2004) (53)
- Validation of Laboratory Screening Criteria for Herpes Simplex Virus Testing of Cerebrospinal Fluid (2007) (52)
- Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. (2007) (49)
- Cutaneous cryptococcosis in solid organ transplant recipients. (2010) (49)
- Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic (2021) (48)
- Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds (2016) (47)
- Rationale for Reading Fluconazole MICs at 24 Hours Rather than 48 Hours When Testing Candida spp. by the CLSI M27-A2 Standard Method (2008) (46)
- Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard (2017) (45)
- Burkholderia glumae Infection in an Infant with Chronic Granulomatous Disease (2006) (42)
- Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds (2015) (41)
- Echinocandins: role in antifungal therapy, 2005 (2005) (41)
- Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species (2017) (40)
- Fatal Apophysomyces elegans Infection Transmitted by Deceased Donor Renal Allografts (2010) (38)
- A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases (2017) (37)
- Nonmolecular methods for the diagnosis of respiratory fungal infections. (2014) (36)
- Antifungal Resistance Trends Towards the Year 2000 (1997) (35)
- A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (2018) (33)
- Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species. (2015) (33)
- Identifying Predictors of Central Nervous System Disease in Solid Organ Transplant RecipientsWith Cryptococcosis (2010) (27)
- Cryptococcus neoformans Isolates from Transplant Recipients Are Not Selected for Resistance to Calcineurin Inhibitors by Current Immunosuppressive Regimens (2005) (26)
- COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study (2021) (25)
- Fungal diagnostics in pneumonia. (2011) (24)
- Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (Version 2.0), Roche CMV UL54 Analyte-Specific Reagent, and QIAGEN RealArt CMV LightCycler PCR Reagent Tests Using AcroMetrix OptiQuant CMV DNA Quantification Panels and Specimens from Allogeneic-Stem-Cell Transplant Recipients (2007) (24)
- Development and Evaluation of a Calibrator Material for Nucleic Acid-Based Assays for Diagnosing Aspergillosis (2013) (23)
- Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory. (2014) (23)
- Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections (2016) (23)
- Fungal infections in transplant and oncology patients. (2010) (23)
- Spontaneous dermal abscesses and ulcers as a result of Serratia marcescens. (2003) (22)
- Reproducibility of Low Galactomannan Enzyme Immunoassay Index Values Tested in Multiple Laboratories (2005) (22)
- Initial Characterization of Micafungin Pulmonary Delivery via Two Different Nebulizers and Multivariate Data Analysis of Aerosol Mass Distribution Profiles (2009) (19)
- Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens (2015) (19)
- The impact of caspase-12 on susceptibility to candidemia (2011) (18)
- Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC. (2021) (18)
- Infections after kidney transplantation. Does age matter? (2019) (17)
- Oral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients (2020) (17)
- Long-Term Stability at −20°C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens (2014) (17)
- Role of autophagy genetic variants for the risk of Candida infections. (2014) (16)
- Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus–positive kidney transplant recipient (2019) (15)
- In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols (2011) (15)
- Prevalence of Renal Anomalies Following Urinary Tract Infections in Hospitalized Infants Less Than Two Months of Age (2009) (14)
- Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial (2021) (14)
- Caspofungin for invasive candidiasis at a tertiary care medical center. (2006) (14)
- MORTALITY AND NEURODEVELOPMENTAL OUTCOME AFTER STAPHYLOCOCCUS AUREUS BACTEREMIA IN INFANTS (2007) (13)
- Non-Aspergillus fungal pneumonia in transplant recipients. (2005) (11)
- Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature (2019) (11)
- Single-center analysis of infectious complications in older adults during the first year after kidney transplantation (2018) (11)
- Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. (2010) (10)
- Invasive Mycobacterium abscessus Complex Infection after Cardiac Surgery: Epidemiology, Management, and Clinical Outcomes. (2020) (10)
- Detection of BK polyomavirus after kidney transplantation: a comparison of urine electron microscopy with plasma polymerase chain reaction (2013) (9)
- Prophylaxis of invasive mycoses in solid organ transplantation. (2002) (9)
- Cryptococcosis after solid organ transplantation (2005) (9)
- Charting the Path Forward Development, Goals and Initiatives of the 2019 IDSA Strategic Plan. (2019) (8)
- Outcomes of Deflect-1: A Multicenter, Blinded, Randomized Clinical Trial of Fidaxomicin (FDX) Vs. Placebo (PLC) for Prophylaxis of Clostridium Difficile Associated Diarrhea (CDAD) in Subjects Undergoing Hematopoietic Stem Cell Transplantation (HSCT) (2016) (8)
- Phaeohyphomycoses (Brown-Black Moulds) (2011) (8)
- Prophylaxis of invasive mycoses in solid organ transplantation (2002) (7)
- Strategies for the prevention of infection after solid organ transplantation (2006) (7)
- New developments in the diagnosis and treatment of infections in lung transplant recipients. (2004) (7)
- Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Utilizing a Preemptive Strategy. (2019) (6)
- 1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI) (2020) (6)
- Infections in Cancer Patients:Infections in Cancer Patients (2005) (6)
- Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study (2020) (6)
- Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. (2006) (6)
- Drug Resistance in Cryptococcosis (2017) (5)
- Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial (2022) (5)
- Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections (2022) (5)
- Delayed mortality among solid organ transplant recipients hospitalized for COVID-19 (2022) (5)
- Long-Term Stability at -20 degrees C of Aspergillus Galactomannan in Serum and Bronchoalveolar Lavage Specimens (4)
- Galactomannan and advances in fungal diagnostics (2005) (4)
- Hepatitis B core antibody‐positive donors in cardiac transplantation: a single‐center experience (2014) (4)
- A Cluster of Mycobacterium abscessus Among Lung Transplant Patients: Investigation and Mitigation (2015) (4)
- The host transcriptional response to Candidemia is dominated by neutrophil activation and heme biosynthesis and supports novel diagnostic approaches (2021) (4)
- Invasive pulmonary aspergillosis. (2009) (4)
- Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience (2018) (4)
- Nebulizer Delivery of Micafungin Aerosols (2011) (3)
- Prevention of invasive fungal infections in lung transplant patients (2008) (3)
- Reply to “Insufficient Demonstration of Long-Term Stability of Aspergillus Galactomannan” (2014) (3)
- 123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI) (2021) (3)
- Curvularia alcornii Aortic Pseudoaneurysm Following Aortic Valve Replacement: Case Report and Review of the Literature (2021) (3)
- Safety of Inhaled Amphotericin B Lipid Complex as Antifungal Prophylaxis in Lung Transplant Recipients (2022) (3)
- 1758. Epidemiology of Invasive Mycoplasma and Ureaplasma Infections Early after Lung Transplantation (2019) (3)
- Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSA. (2020) (2)
- (676) - Mycobacterium Abscessus Infection in Patients with Ventricular Assist Devices (2017) (2)
- Infection in Kidney Transplant Recipients (2019) (2)
- Hospital Management of Tuberculosis in a Region With a Low Incidence of Tuberculosis and a High Prevalence of Nontuberculous Mycobacteria (2001) (2)
- Invasive Mycobacterium abscessus Infection in Heart Transplant Recipients (2017) (2)
- Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction (2017) (2)
- Genomic characterization of recurrent mold infections in thoracic transplant recipients (2018) (2)
- Mycobacterium abscessus Infection in Solid Organ Transplant Recipients (2016) (1)
- Reply to Authors (Drs. Marinelli and Rotstein). (2020) (1)
- Current Controversies in the Treatment of Fungal Infections (2011) (1)
- Editorial: Infections of the immunocompromised host: a musing on the changing times. (2020) (1)
- 1599. Rejection Outcomes in Lung Transplant Recipients Post Respiratory Syncytial Virus Infections (2018) (1)
- The host transcriptional response to Candidemia is dominated by neutrophil activation and heme biosynthesis and supports novel diagnostic approaches (2021) (1)
- A Multicenter Prospective Registry Study of Lung Transplant Recipients Hospitalized with COVID-19 (2021) (1)
- Cryptococcosis in Transplant Recipients (2011) (1)
- Invasive Fungal Disease in the Transplant Population: An Overview (2019) (1)
- Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? (2021) (1)
- The Timing and Epidemiology of Enterococcus Faecium and E. Faecalis Bloodstream Infections (BSI) in Patients with Acute Leukemia Receiving Chemotherapy (2017) (1)
- 2885. A Host Transcriptional Signature for Accurate Diagnosis of Candidemia in the Hospital Setting (2019) (1)
- 38 – Opportunistic Mycoses (2016) (1)
- The impact of caspase-12 on susceptibility to candidemia (2011) (0)
- The Utility of Surveillance Bronchoscopy for the Detection of Subclinical Infection after Lung Transplantation (2008) (0)
- Impact of Respiratory Syncytial Virus Infection on Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients (2019) (0)
- Infections in Cancer Patients Edited by John N. Greene New York: Marcel Dekker, 2004. 534 pp., illustrated. $179.95 (cloth) (2004) (0)
- Severity of Clostridium difficile Associated Diarrhea in Solid-Organ Transplant Patients: 458 (2006) (0)
- Epidemiology of fungal infections: What, where, and when (2019) (0)
- Reply to Marinelli and Rotstein. (2021) (0)
- Antifungal management in risk groups: Solid organ transplant recipients (2019) (0)
- Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus–positive kidney transplant recipient (2019) (0)
- Investigational CYP51 Inhibitors VT-1161 and VT-1129 Show Strong Activity In Vitro Against Candida krusei (2016) (0)
- American Transplant Congress 2009 Program Planning Committees (2009) (0)
- 1570. Cumulative Antibiotic Exposure and Risk for Candidemia (2022) (0)
- 632. Donor-Derived Mollicute Infections in Lung Transplant Recipients: a Prospective Study of Donor Respiratory Tract Screening and Recipient Outcomes (2022) (0)
- Assessment of Discontinuations and Anti-Cytomegalovirus Treatment Switching in Post-Transplant Refractory/ Resistant Cytomegalovirus Infections: Safety and Sensitivity Analyses from a Phase 3 Randomized Trial (2022) (0)
- Epidemiology, Management, and Clinical Outcomes of Extrapulmonary Mycobacterium abscessus Complex Infections in Heart Transplant and Ventricular Assist Device Recipients. (2023) (0)
- Immunological regulations of prostate-specific antigen (1994) (0)
- Transcriptomic approaches elucidate novel aspects of the host immune response to candidemia (2020) (0)
- Survival following lung transplantation (LT) of cystic fibrosis (CF) patients infected with burkholderia cepacia complex (BCC) (2004) (0)
- Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections (2022) (0)
- Single-center analysis of infectious complications in older adults during the first year after kidney transplantation (2018) (0)
- Evaluation of a digital microfluidic real-time PCR platform to detect DNA of Candida albicans in blood (2012) (0)
- Antifungal Management in Risk Groups: Transplant Recipients (2009) (0)
- Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies (2022) (0)
- Early colonization with pseudomonas in cystic fibrosis (CF) lung transplant recipients is associated with poor long-term survival (2002) (0)
- Clinical and Genomic Characterization of Recurrent Enterococcal Bloodstream Infection in Patients With Acute Leukemia (2018) (0)
- Recurrent Enterococcal Bloodstream Infection in Patients with Acute Leukemia (2017) (0)
- Epidemiology of surgical site infections after solid organ transplants in the period 2015–2019: A single‐center retrospective cohort study (2022) (0)
- 156. Clinical Characteristics and Acute-phase Cytokine Response of Solid-Organ Transplant Recipients with Bloodstream Infections Differs According to Bacterial Type and Transplant Status (2019) (0)
- Invasive Aspergillosis: New Diagnostic Platforms and Targets (2008) (0)
- Incidence of invasive fungal infections following the use of prophylactic aerosolized amphotericin B lipid complex in lung transplant recipients (2012) (0)
- Fungal Disease in the Immunocompromised Cancer Patient: New Strategies in the Era of Prophylaxis (2007) (0)
- Computed Tomography (CT) Findings of Invasive Pulmonary Aspergillosis (IPA) in Solid Organ Transplant (SOT) Recipients (2009) (0)
- Clinical Issues in the Practice of Infectious Diseases (2005) (0)
- 1600. An Optimal Respiratory Syncytial Virus (RSV) Treatment in Lung Transplant Recipients: Oral Ribavirin, Inhaled Ribavirin, or Conservative Approach (2018) (0)
- Nucleic Acid Testing (NAT) for Screening Organ Donors (2009) (0)
- AST/IDSA Guidelines: Managing Viral Infections (2009) (0)
- Mycology and Transplant ID (2009) (0)
- Transplant/Oncology ID (2017) (0)
- Invasive Mycobacterium abscessus Infection after Cardiac Surgery: Epidemiology and Clinical Outcomes (2017) (0)
- Viral Infections -- New Challenges in Transplantation (2007) (0)
- Breakthrough Invasive Candidiasis in Patients on Micafungin (cid:1) † (2010) (0)
- Transplant/Oncology ID Careers (2018) (0)
- Effect of Chlortetracycline on Vitamin B6 and Amino Acid Decarboxylase in Bacteria from the Alimentary Tract of the Chick (1960) (0)
- 51: Successful Management of Pump Pocket Infections in Patients with Implanted Left Ventricular Assist Devices (2009) (0)
- Infections in the Transplant Recipient (2007) (0)
- An Increase in Invasive Infections due to Corynebacterium striatum at an Academic Medical Center (2017) (0)
- Contributors (1973) (0)
- The New Age of TB Diagnostics (2009) (0)
- 1017. Impact of Enterococcal Bloodstream Infection on Mortality in Patients With Acute Myelogenous Leukemia (2018) (0)
- 2223. A comparative analysis of the detection of UTI pathogens via culture method and the Open Array-nanofluidic real time PCR method (2022) (0)
This paper list is powered by the following services:
Other Resources About Barbara Dudley Alexander
What Schools Are Affiliated With Barbara Dudley Alexander?
Barbara Dudley Alexander is affiliated with the following schools:
